Expanding the therapeutic opportunities in advanced prostate cancer

Learning objectives:

After attending this meeting, participants should be able to:

• Discuss ongoing changes and the subsequent impact on the treatment landscape of advanced prostate cancer
• Review advances in therapeutic strategies for mHSPC
• Explore practical management of treatment options in nmCRPC

Faculty:

• Eleni Efstathiou (USA)
• Noel Clarke (UK)
• Nicolas Mottet (France)
• Kim Chi (Canada)
• Álvaro Pinto (Spain)
• Laura-Maria Krabbe (Germany)